Last reviewed · How we verify

Vaginal Lactobacillus Dual Probiotic Capsules

Guangdong Longchuangji Pharmaceutical Co., Ltd. · Phase 3 active Small molecule

This drug restores the balance of vaginal microbiota by introducing beneficial Lactobacillus strains.

This drug restores the balance of vaginal microbiota by introducing beneficial Lactobacillus strains. Used for Treatment of bacterial vaginosis.

At a glance

Generic nameVaginal Lactobacillus Dual Probiotic Capsules
SponsorGuangdong Longchuangji Pharmaceutical Co., Ltd.
Drug classProbiotic
ModalitySmall molecule
Therapeutic areaGynecology
PhasePhase 3

Mechanism of action

The probiotic capsules contain a combination of Lactobacillus strains that help to suppress the growth of pathogenic bacteria in the vagina, promoting a healthy vaginal microbiome.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: